GlassScriptPrepare for your visit
Kuldip Singh Banwait
Gastroenterology (Internal Medicine) · Amarillo, TX · NPI 1699877670
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$12,114.89
in general payments reported to CMS, 2019-2025 · $1,479 in 2025
The $1,479 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Who reported paying
General payments only, top 6 by amount.
- Medtronic, INC. $5,546.36
- Abbvie INC. $2,473.35
- Takeda Pharmaceuticals U.S.A., INC. $900.49
- Pfizer INC. $518.94
- Gilead Sciences, INC. $450.99
- Madrigal Pharmaceuticals $287.80
Drugs and devices associated with these payments
Mavyret Entyvio Skyrizi Rinvoq Velsipity Dupixent Ibsrela Rezdiffra Xeljanz Voquezna Tremfya Resmetirom
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Kuldip Banwait listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/76551/kuldip-singh-banwait